These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 16794486

  • 1. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D, Sairam MR, Neves MF, Schiffrin EL, Touyz RM.
    J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
    [Abstract] [Full Text] [Related]

  • 2. Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension.
    Javeshghani D, Touyz RM, Sairam MR, Virdis A, Neves MF, Schiffrin EL.
    Hypertension; 2003 Oct; 42(4):761-7. PubMed ID: 12885794
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
    Bao W, Behm DJ, Nerurkar SS, Ao Z, Bentley R, Mirabile RC, Johns DG, Woods TN, Doe CP, Coatney RW, Ohlstein JF, Douglas SA, Willette RN, Yue TL.
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro Keller A, Haymann JP, Baud L.
    Circ Res; 2008 Mar 28; 102(6):720-8. PubMed ID: 18258859
    [Abstract] [Full Text] [Related]

  • 10. Cerebral vascular effects of angiotensin II: new insights from genetic models.
    Faraci FM, Lamping KG, Modrick ML, Ryan MJ, Sigmund CD, Didion SP.
    J Cereb Blood Flow Metab; 2006 Apr 28; 26(4):449-55. PubMed ID: 16094317
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD, Bagatell SJ, Miller CS, Mouton CR, Seth DM, Mullins JJ.
    J Renin Angiotensin Aldosterone Syst; 2006 Jun 28; 7(2):74-86. PubMed ID: 17083061
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD, Albornoz F, Griffin JP, Crandall DL, Elokdah H, Fogo AB, Vaughan DE, Brown NJ.
    Arterioscler Thromb Vasc Biol; 2005 Feb 28; 25(2):365-71. PubMed ID: 15576638
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Potentiation of vascular oxidative stress and nitric oxide-mediated endothelial dysfunction by high-fat diet in a mouse model of estrogen deficiency and hyperandrogenemia.
    Javeshghani D, Schiffrin EL, Sairam MR, Touyz RM.
    J Am Soc Hypertens; 2009 Feb 28; 3(5):295-305. PubMed ID: 20409973
    [Abstract] [Full Text] [Related]

  • 17. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP, Schnackenberg CG.
    Semin Nephrol; 2000 Sep 28; 20(5):417-25. PubMed ID: 11022893
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase.
    Sarr M, Chataigneau M, Martins S, Schott C, El Bedoui J, Oak MH, Muller B, Chataigneau T, Schini-Kerth VB.
    Cardiovasc Res; 2006 Sep 01; 71(4):794-802. PubMed ID: 16822492
    [Abstract] [Full Text] [Related]

  • 20. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S, Aihara K, Ikeda Y, Sumitomo Y, Yoshida S, Ise T, Iwase T, Ishikawa K, Azuma H, Akaike M, Matsumoto T.
    Circ Res; 2008 Jan 04; 102(1):68-76. PubMed ID: 17967781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.